BTMD (Biote Corp) Short-Term Debt to Capital
The asset value tracked on the chart, in the context of pressure from major chains and pharma behemoths, stands at 0.00. biote Corp. (BTMD) specializes in long-term hormone therapy for clinics and individuals, occupying the anti-aging medicine niche. The business is currently aggressively expanding its presence across various states, implementing digital physician training and broadening its supplement portfolio to drive profitability.
Metric breakdowns and analytics for biote.com (BTMD)
biote Corp. (BTMD) is developing a closed medical ecosystem for bioidentical therapy, creating high barriers to customer churn. By analyzing the trend of long-term debt to equity, one can assess the business's dependence on the cost of borrowed capital. This metric compares liabilities with maturities exceeding one year against equity to determine the degree of financial leverage. The stability of this ratio confirms the model's resilience to cash flow gaps and interest rate risks.